← Open Payments lookup

ALICE MAO: Open Payments

NPI 1851309488 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$170,127 in 276 payments from 23 companies in 2025. Trend: 2023 $171,732 · 2024 $129,350 · 2025 $170,127

Speaker / faculty: $85,455Honoraria: $58,360Travel & lodging: $20,169Food & beverage: $6,143
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.97$94,202
Supernus Pharmaceuticals, Inc.63$56,559
Tris Pharma Inc27$16,823
Vanda Pharmaceuticals Inc.12$422
Axsome Therapeutics, Inc.12$310
Neurocrine BioSciences, Inc.9$224
ABBVIE INC.12$218
Teva Pharmaceuticals USA, Inc.2$215
Corium, LLC7$187
E.R. Squibb & Sons, L.L.C.2$154

Products named: REXULTI, Qelbree, Dyanavel XR, FANAPT, Auvelity, Onyda XR, INGREZZA, VRAYLAR.

Industry payments across TX — which companies pay providers there.